Hairy Cell Leukemia in Adults

We provide ongoing, compassionate care and monitoring for people with hairy cell leukemia. This is a rare, slow-growing cancer of infection-fighting white blood cells. Our specialists use sophisticated tests to diagnose this chronic disease and create a personalized treatment plan to manage it. Our team of oncologists, nurses, physical therapists, psychologists, and social workers can help enhance your wellbeing throughout treatment and recovery.

Clinical Trials and Research Studies

Phase 5

A Phase 1/2 Open-label Study Investigating the Safety Tolerability and Efficacy of ASP7517 in subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Learn More

Phase 2

Single-arm open label phase II study of MBG453 (sabatolimab) added to FDA approved Hypomethylating agents of investigator s choice (IV/SC/Oral) for patients with intermediate high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R criteria (US multi-center) (STIMULUS MDS-US)

Learn More

Phase 3

A Phase 3 Randomized Multicenter Double-Blind Placebo-Controlled Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

Learn More

Phase 1

A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Learn More